BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/16/2020 7:58:40 AM | Browse: 732 | Download: 1047
Publication Name World Journal of Gastroenterology
Manuscript ID 52599
Country/Territory Japan
Received
2019-11-23 07:19
Peer-Review Started
2019-11-23 07:19
To Make the First Decision
Return for Revision
2019-12-23 14:08
Revised
2020-01-07 11:13
Second Decision
2020-01-09 09:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-01-11 14:04
Articles in Press
2020-01-11 14:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-01-13 14:02
Publish the Manuscript Online
2020-01-16 07:58
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Systematic Reviews
Article Title Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
Manuscript Source Invited Manuscript
All Author List Takumi Onoyama, Yohei Takeda, Taro Yamashita, Wataru Hamamoto, Yuri Sakamoto, Hiroki Koda, Soichiro Kawata, Kazuya Matsumoto and Hajime Isomoto
ORCID
Author(s) ORCID Number
Takumi Onoyama http://orcid.org/0000-0003-0310-0720
Yohei Takeda http://orcid.org/0000-0003-1096-5909
Taro Yamashita http://orcid.org/0000-0003-2726-3356
Wataru Hamamoto http://orcid.org/0000-0003-2220-9916
Yuri Sakamoto http://orcid.org/0000-0001-9682-6410
Hiroki Koda http://orcid.org/0000-0003-4000-6899
Soichiro Kawata http://orcid.org/0000-0002-2194-0582
Kazuya Matsumoto http://orcid.org/0000-0002-5680-4791
Hajime Isomoto http://orcid.org/0000-0001-8998-7865
Funding Agency and Grant Number
Corresponding Author Takumi Onoyama, MD, PhD, Doctor, Department of Multidisciplinary Internal Medicine, Tottori University, 36-1 Nishi-cho, Yonago 683-8504, Tottori prefecture, Japan. golf4to@yahoo.co.jp
Key Words Nivolumab; Pembrolizumab; Avelumab; Durvalumab; Atezolizumab; Programmed cell death-1 inhibitor
Core Tip This study systematically reviewed the literature on the programmed cell death-1 inhibitor-related sclerosing cholangitis. Biliary dilation without obstruction, diffuse hypertrophy of the extrahepatic biliary tract and/or multiple strictures of intrahepatic biliary tract, liver dysfunction with a notable increase in biliary tract enzymes relative to hepatic enzymes, normal level of the serum immunoglobulin G4, and a moderate to poor response to steroid therapy, and CD8+ T cell infiltration in the biliary tract were clinical and pathological features of programmed cell death-1 inhibitor-related sclerosing cholangitis.
Publish Date 2020-01-16 07:58
Citation Onoyama T, Takeda Y, Yamashita T, Hamamoto W, Sakamoto Y, Koda H, Kawata S, Matsumoto K, Isomoto H. Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review. World J Gastroenterol 2020; 26(3): 353-365
URL https://www.wjgnet.com/1007-9327/full/v26/i3/353.htm
DOI https://dx.doi.org/10.3748/wjg.v26.i3.353
Full Article (PDF) WJG-26-353.pdf
Full Article (Word) WJG-26-353.docx
PRISMA 2009 Checklist 52599-PRISMA-2009-Checklist-revision.doc
Manuscript File 52599-Review.docx
Answering Reviewers 52599-Answering reviewers.pdf
Audio Core Tip 52599-Audio core tip.m4a
Biostatistics Review Certificate 52599-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 52599-Conflict-of-interest statement.pdf
Copyright License Agreement 52599-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 52599-Language certificate.pdf
Peer-review Report 52599-Peer-review(s).pdf
Scientific Misconduct Check 52599-Scientific misconduct check.pdf
Scientific Editor Work List 52599-Scientific editor work list.pdf